Report Library
View More
Wet AMD KOL- US, South
May 7, 2025
Datamonitor Healthcare Infectious D...
May 6, 2025
Datamonitor Healthcare CV&Met: Sick...
May 6, 2025
Datamonitor Healthcare I&I: Heredit...
May 1, 2025
Podcast: Highlights from AAN 2025
April 30, 2025
Sjögren’s Disease Full Report Avail...
April 30, 2025
Datamonitor Healthcare Oncology Dis...
April 30, 2025
Sjögren’s Disease KOL Interview - N...
April 28, 2025
Datamonitor Healthcare I&I: Dry Eye...
April 28, 2025
Datamonitor Healthcare Oncology: Wa...
April 18, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Wet Age-Related Macular Degeneratio...
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
2025 Biomedtracker Datamonitor Hea...
May 8, 2025
Wet AMD KOL- France
May 8, 2025
Datamonitor Healthcare Oncology: NH...
May 8, 2025
Wet AMD KOL- US, South
May 7, 2025
Datamonitor Healthcare Infectious D...
May 6, 2025
Datamonitor Healthcare CV&Met: Sick...
May 6, 2025
Datamonitor Healthcare I&I: Heredit...
May 1, 2025
Podcast: Highlights from AAN 2025
April 30, 2025
Sjögren’s Disease Full Report Avail...
April 30, 2025
Datamonitor Healthcare Oncology Dis...
April 30, 2025
Sjögren’s Disease KOL Interview - N...
April 28, 2025
Datamonitor Healthcare I&I: Dry Eye...
April 28, 2025
Datamonitor Healthcare Oncology: Wa...
April 18, 2025
Gene, Cell, & RNA Therapy Landscape...
May 16, 2025
Epilepsy KOL Interview - France
May 16, 2025
Datamonitor Healthcare Oncology: Pa...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 15, 2025
Datamonitor Healthcare Infectious D...
May 14, 2025
Wet Age-Related Macular Degeneratio...
May 12, 2025
Datamonitor Healthcare Oncology Dis...
May 9, 2025
2025 Biomedtracker Datamonitor Hea...
May 8, 2025
Wet AMD KOL- France
May 8, 2025
Datamonitor Healthcare Oncology: NH...
May 8, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 5/15/25 | Merck & Co (MRK) | Keytruda for Ovarian Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/14/25 | Arcellx (ACLX) | Anito-cel for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/13/25 | iTeos (ITOS) | Belrestotug for Non-Small Cell Lung Cancer (NSCLC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/10/25 | Novo Nordisk (NVO) | Sogroya for Short Stature / Growth Hormone Deficiency | Subscribers Only | Subscribers Only | Subscribers Only |
| 5/9/25 | AstraZeneca (AZN) | Imfinzi for Bladder Cancer | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 04/01/2025 | Subscribers Only | Subscribers Only | Company - Divestment/Spinoff |
| 04/24/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 05/09/2025 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 05/13/2025 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
| 05/13/2025 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |